Community Action Needed: Please respond to the NIH RFI
ZFIN ID: ZDB-FISH-171019-2
Fish name: y1Tg + MO1-ptger3
Genotype: y1Tg
Targeting Reagent: MO1-ptger3
HUMAN DISEASE MODELED by y1Tg + MO1-ptger3
No data available
GENE EXPRESSION
Gene expression in y1Tg + MO1-ptger3
RNA expression
Expressed Gene Structure Conditions Figures
lyve1b standard conditions Figure 2 with image from Iwasaki et al., 2019
Protein expression No data available
PHENOTYPE
Phenotype in y1Tg + MO1-ptger3
Phenotype Conditions Figures
dorsal longitudinal anastomotic vessel hypoplastic, abnormal standard conditions Fig. 1Fig. 3 from Chen et al., 2017
intersegmental vessel hypoplastic, abnormal standard conditions Fig. 1Fig. 3Fig. 5 from Chen et al., 2017
intersegmental vessel morphology, ameliorated chemical treatment: EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor Fig. 5 from Chen et al., 2017
intersegmental vessel sprouting angiogenesis decreased occurrence, abnormal standard conditions Fig. 1Fig. 3Fig. 5 from Chen et al., 2017
intersegmental vessel sprouting angiogenesis occurrence, ameliorated chemical treatment: EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor Fig. 5 from Chen et al., 2017
lymph vessel lyve1b expression decreased distribution, abnormal standard conditions Figure 2 with image from Iwasaki et al., 2019
lymphangiogenesis disrupted, abnormal standard conditions Figure 1 with image from Iwasaki et al., 2019
thoracic duct aplastic/hypoplastic, abnormal standard conditions Figure 1 with image from Iwasaki et al., 2019
vascular lymphangioblast aplastic/hypoplastic, abnormal standard conditions Figure 1 with image from Iwasaki et al., 2019
vascular lymphangioblast EGFP expression decreased distribution, abnormal standard conditions Figure 1 with image from Iwasaki et al., 2019
vascular lymphangioblast EGFP expression spatial pattern, abnormal standard conditions Figure 1 with image from Iwasaki et al., 2019

CITATIONS  (2)